— Know what they know.
Not Investment Advice

AXNX NASDAQ

Axonics, Inc.
1W: +0.8% 1M: +1.0% 3M: +2.9% 1Y: +24.1% 3Y: +16.7% 5Y: +178.5%
$70.98
Last traded 2024-11-15 — delisted
NASDAQ · Healthcare · Medical - Devices · $3.6B mcap · 50M float · 0.908% daily turnover

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$366M +33.9% ▲
5Y CAGR: +249.1%
Gross Profit
$275M +38.9% ▲
5Y CAGR: +279.0%
Operating Income
-$26M +38.5% ▲
Net Income
-$6M +89.8% ▲
EPS (Diluted)
$-0.12 +90.6% ▲
EBITDA
$8M +116.5% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
Revenue$14M$112M$180M$274M$366M
YoY Growth+1854.7%+707.1%+61.6%+51.8%+33.9%
Cost of Revenue$6M$44M$65M$76M$92M
Gross Profit$7M$67M$116M$198M$275M
Gross Margin53.0%60.2%64.2%72.2%74.9%
R&D Expenses$20M$29M$37M$34M$35M
SG&A Expenses$68M$92M$139M$196M$235M
Operating Expenses$88M$121M$183M$240M$270M
Operating Income-$81M-$54M-$67M-$42M-$26M
Operating Margin-583.2%-48.2%-37.4%-15.5%-7.1%
Interest Expense$2M$2M$7M$2M$0
Income Before Tax-$80M-$55M-$79M-$62M-$9M
Tax Expense$1K$1K$782K-$3M-$3M
Net Income-$80M-$55M-$80M-$60M-$6M
Net Margin-578.4%-49.2%-44.4%-21.8%-1.7%
EPS (Diluted)$-2.80$-1.48$-1.86$-1.28$-0.12
EBITDA-$78M-$51M-$62M-$47M$8M
Shares Outstanding29M37M43M47M49M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms